Martin G. Belinsky

5.5k total citations
51 papers, 4.2k citations indexed

About

Martin G. Belinsky is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Gastroenterology. According to data from OpenAlex, Martin G. Belinsky has authored 51 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Pediatrics, Perinatology and Child Health and 14 papers in Gastroenterology. Recurrent topics in Martin G. Belinsky's work include Drug Transport and Resistance Mechanisms (26 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Gastrointestinal Tumor Research and Treatment (14 papers). Martin G. Belinsky is often cited by papers focused on Drug Transport and Resistance Mechanisms (26 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Gastrointestinal Tumor Research and Treatment (14 papers). Martin G. Belinsky collaborates with scholars based in United States, Japan and Russia. Martin G. Belinsky's co-authors include Gary D. Kruh, Zhe‐Sheng Chen, Hao Zeng, Anil K. Jaiswal, Irina Shchaveleva, Elizabeth Hopper-Borge, Kun Hee Lee, Elena Kotova, Yanping Guo and Philip A. Rea and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Martin G. Belinsky

50 papers receiving 4.1k citations

Peers

Countries citing papers authored by Martin G. Belinsky

Since Specialization

Citations

This map shows the geographic impact of Martin G. Belinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin G. Belinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin G. Belinsky more than expected).

Fields of papers citing papers by Martin G. Belinsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin G. Belinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin G. Belinsky. The network helps show where Martin G. Belinsky may publish in the future.

Co-authorship network of co-authors of Martin G. Belinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Martin G. Belinsky. A scholar is included among the top collaborators of Martin G. Belinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin G. Belinsky. Martin G. Belinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor 2021 ·Cancers ·(unknown), (unknown), Shuai Ye, Martin G. Belinsky, (unknown), Jeffrey M. Farma, Sanjay S. Reddy, Samuel Litwin, Karthik Devarajan, Alex Campos, Yi Yu, Brian Schwartz, Margaret von Mehren, Lori Rink	4
2	Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment 2020 ·JCI Insight ·Shuai Ye, (unknown), (unknown), Lillian R. Klug, (unknown), Martin G. Belinsky, (unknown), Margret B. Einarson, Karthik Devarajan, Yan Zhou, Samuel Litwin, Michael C. Heinrich, Ronald P. DeMatteo, Margaret von Mehren, James S. Duncan, Lori Rink	6
3	Succinate dehydrogenase deficiency in a PDGFRA mutated GIST 2017 ·BMC Cancer ·Martin G. Belinsky, Kathy Q. Cai, Yan Zhou, Biao Luo, Jianming Pei, Lori Rink, Margaret von Mehren	17
4	Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor 2016 ·Clinical Cancer Research ·(unknown), Harsh B. Pathak, Martin G. Belinsky, (unknown), Karthik Devarajan, Yan Zhou, Andrew K. Godwin, Margaret von Mehren, Lori Rink	30
5	Contribution of Abcc10 (Mrp7) to In Vivo Paclitaxel Resistance as Assessed in Abcc10−/− Mice 2011 ·Cancer Research ·Elizabeth Hopper-Borge, Timothy W. Churchill, (unknown), Émmanuelle Nicolas, Joely D. Jacobs, (unknown), Yehong Kuang, Alex Grinberg, Heiner Westphal, Zhe‐Sheng Chen, Andres J. Klein–Szanto, Martin G. Belinsky, Gary D. Kruh	59
6	High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors 2009 ·Genes Chromosomes and Cancer ·Martin G. Belinsky, Yuliya Skorobogatko, Lori Rink, Jianming Pei, Kathy Q. Cai, Lisa Vanderveer, David Riddell, Erin Merkel, Chi Tarn, Burton Eisenberg, Margaret von Mehren, Joseph R. Testa, Andrew K. Godwin	33
7	The organic solute transporter α-β, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis 2008 ·Proceedings of the National Academy of Sciences ·Anuradha Rao, Jamie Haywood, Ann L. Craddock, Martin G. Belinsky, Gary D. Kruh, Paul A. Dawson	179
8	ABCC10, ABCC11, and ABCC12 2006 ·Pflügers Archiv - European Journal of Physiology ·Gary D. Kruh, Yanping Guo, Elizabeth Hopper-Borge, Martin G. Belinsky, Zhe‐Sheng Chen	111
9	Analysis of the contribution of MRP3 to in vivo chemosensitivity using knock out mice. 2004 ·Cancer Research ·Martin G. Belinsky, Irina Shchaveleva, Zhe‐Sheng Chen, Alan C. Sartorelli, Gary D. Kruh	1
10	Transport of Bile Acids, Sulfated Steroids, Estradiol 17-β-d-Glucuronide, and Leukotriene C4 by Human Multidrug Resistance Protein 8 (ABCC11) 2004 ·Molecular Pharmacology ·Zhe‐Sheng Chen, Yanping Guo, Martin G. Belinsky, Elena Kotova, Gary D. Kruh	107
11	The MRP family of drug efflux pumps 2003 ·Oncogene ·Gary D. Kruh, Martin G. Belinsky	484
12	Characterization of the Transport Properties of Human Multidrug Resistance Protein 7 (MRP7, ABCC10) 2003 ·Molecular Pharmacology ·Zhe‐Sheng Chen, Elizabeth Hopper-Borge, Martin G. Belinsky, Irina Shchaveleva, Elena Kotova, Gary D. Kruh	142
13	Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). 2002 ·PubMed ·Martin G. Belinsky, Zhe‐Sheng Chen, Irina Shchaveleva, Hao Zeng, Gary D. Kruh	201
14	多剤耐性蛋白質(MRP)3とMRP1によるメトトレキセート(MTX)と葉酸塩の輸送ポリグルタミル化がMTX輸送に及ぼす効果 2001 ·Cancer Research ·(unknown), (unknown), Martin G. Belinsky, (unknown), Gary D. Kruh	1
15	MRP Subfamily Transporters and Resistance to Anticancer Agents 2001 ·Journal of Bioenergetics and Biomembranes ·Gary D. Kruh, Hao Zeng, Philip A. Rea, Guosheng Liu, Zhe‐Sheng Chen, Kun Hee Lee, Martin G. Belinsky	129
16	Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. 1999 ·PubMed ·Hao Zeng, Lisa J. Bain, Martin G. Belinsky, Gary D. Kruh	137
17	Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells. 1998 ·PubMed ·Naomi Laing, Martin G. Belinsky, Gary D. Kruh, Daphne W. Bell, Jonathan T. Boyd, Linda R. Barone, Joseph R. Testa, Kenneth D. Tew	65
18	ARE- and TRE-mediated Regulation of Gene Expression 1995 ·Journal of Biological Chemistry ·Tao Xie, Martin G. Belinsky, Yuehang Xu, Anil K. Jaiswal	123
19	NAD(P)H:Quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues 1993 ·Cancer and Metastasis Reviews ·Martin G. Belinsky, Anil K. Jaiswal	228
20	Non-ribozyme sequences enhance self-cleavage of ribozymes derived from Hepatitis delta virus 1991 ·Nucleic Acids Research ·Martin G. Belinsky, Gail Dinter-Gottlieb	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact